CXCR3 antagonists (Pharmacopeia)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCXCR3 antagonists (Pharmacopeia)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 3 antagonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsMultiple SclerosisIrritable Bowel SyndromeArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacopeia Llc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisIrritable Bowel SyndromeArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A